AU2002304814A1 - Protein-protein interactions in adipocytes - Google Patents

Protein-protein interactions in adipocytes

Info

Publication number: AU2002304814A1
Authority: AU; Australia
Prior art keywords: protein; adipocytes; interactions; protein interactions
Prior art date: 2001-03-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002304814A

Inventor

Laurent Daviet

Pierre Legrain

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Aton SA

Original Assignee

Hybrigenics SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-14

Filing date

2002-03-14

Publication date

2002-11-05

2002-03-14 Application filed by Hybrigenics SA filed Critical Hybrigenics SA

2002-11-05 Publication of AU2002304814A1 publication Critical patent/AU2002304814A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Investigating Or Analysing Biological Materials (AREA)

AU2002304814A 2001-03-14 2002-03-14 Protein-protein interactions in adipocytes Abandoned AU2002304814A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US27573401P	2001-03-14	2001-03-14
US60/275,734		2001-03-14
PCT/EP2002/003768 WO2002086122A2 (en)	2001-03-14	2002-03-14	Protein-protein interactions in adipocytes

Publications (1)

Publication Number	Publication Date
AU2002304814A1 true AU2002304814A1 (en)	2002-11-05

Family

ID=23053586

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002304814A Abandoned AU2002304814A1 (en)	2001-03-14	2002-03-14	Protein-protein interactions in adipocytes

Country Status (2)

Country	Link
AU (1)	AU2002304814A1 (en)
WO (1)	WO2002086122A2 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE506075T1 (en)	2000-12-08	2011-05-15	Curagen Corp	METHOD FOR DETERMINING AND TREATING TUBEROUS-SCLEROSIS COMPLEX-ASSOCIATED DISEASES
US20040072997A1 (en) *	2000-12-20	2004-04-15	Alsobrook John P.	Therapeutic polypeptides, nucleic acids encoding same, and methods of use
CA2441936A1 (en)	2001-03-23	2002-10-03	Yoshihiro Nakatani	Methods and compositions for modulating tumor suppression
US20040126762A1 (en) *	2002-12-17	2004-07-01	Morris David W.	Novel compositions and methods in cancer
EP1625151A2 (en) *	2003-05-13	2006-02-15	The Board Of Regents Of The University Of Oklahoma	Comparative ligand mapping from mhc class i positive cells
US20050272651A1 (en) *	2004-02-26	2005-12-08	New York University	Methods for treating breast cancer using NRIF3 related molecules
WO2006023211A2 (en) *	2004-07-29	2006-03-02	Albert Einstein College Of Medicine Of Yeshiva University	Antigens targeted by pathogenic ai4 t cells in type 1 diabetes and uses thereof
WO2006132701A2 (en)	2005-04-04	2006-12-14	Rutgers, The State University	Methods and kits for regulation of microtubule assembly and dendrite growth and branching
WO2006133566A1 (en)	2005-06-17	2006-12-21	National Research Council Of Canada	NOVEL Aß-BINDING PROTEIN AND ITS PEPTIDE DERIVATIVES AND USES THEREOF
US8309525B2 (en)	2007-05-30	2012-11-13	Albert Einstein College Of Medicine Of Yeshiva University	Treatment of type 2 diabetes, metabolic syndrome, myocardial injury and neurodegeneration with humanin and analogs thereof
KR101229819B1 (en) *	2009-10-19	2013-02-08	코아스템(주)	Compositions for Improving Migration Potential of Stem Cells
US9670259B2 (en)	2013-03-14	2017-06-06	University Of Rochester	Method of inhibiting angiogenesis using inhibitors of G-protein-coupled receptor kinase interacting protein-1 (GIT1)
WO2014150350A1 (en) *	2013-03-15	2014-09-25	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Inhibitors of the linear ubiquitin chain assembly complex (lubac) and related methods
US10857219B2 (en)	2014-03-28	2020-12-08	The Board Of Regents Of The University Of Oklahoma	Compositions comprising soluble HLA/M. tuberculosis-specific ligand complexes and methods of production and use thereof
GB201601136D0 (en)	2016-01-21	2016-03-09	Mörgelin Matthias And Abdillahi Suado M	Novel polypeptides and medical uses thereof
JP7449092B2 (en)	2017-01-30	2024-03-13	ナショナルリサーチカウンシルオブカナダ	Blood-brain barrier migration compounds and their uses
AU2020216135A1 (en) *	2019-01-28	2021-08-05	Cohbar, Inc.	Therapeutic peptides
US20220332774A1 (en) *	2019-08-12	2022-10-20	Cohbar, Inc.	Therapeutic mitochondrial peptides
US20220324925A1 (en) *	2019-08-15	2022-10-13	Cohbar, Inc.	Therapeutic peptides
US20220324912A1 (en) *	2019-08-15	2022-10-13	Cohbar, Inc.	Therapeutic peptides
EP4013440A4 (en) *	2019-08-15	2024-01-10	Cohbar Inc.	THERAPEUTIC PEPTIDES
US20220306691A1 (en) *	2019-08-15	2022-09-29	Cohbar, Inc.	Therapeutic peptides
WO2021030749A1 (en) *	2019-08-15	2021-02-18	Cohbar, Inc.	Therapeutic peptides
WO2021030792A1 (en) *	2019-08-15	2021-02-18	Cohbar, Inc.	Therapeutic peptides
TW202204375A (en) *	2020-04-15	2022-02-01	美商寇峇有限公司	Method of treating coronavirus infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5364772A (en) *	1992-07-20	1994-11-15	Wayne State University	DNA molecule encoding the β3 -adrenergic receptor
EP0600136B1 (en) *	1992-12-01	2002-03-13	Centre National De La Recherche Scientifique	Intron/Exon structure of the human and mouse Beta 3 Adrenergic receptors genes
FR2733513B1 (en) *	1995-04-25	1997-07-18	Centre Nat Rech Scient	IMMORTALIZED LINES OF CELLS FROM HUMAN FATTY TISSUE, THEIR PREPARATION PROCESS AND THEIR APPLICATIONS
US6187535B1 (en) *	1998-02-18	2001-02-13	Institut Pasteur	Fast and exhaustive method for selecting a prey polypeptide interacting with a bait polypeptide of interest: application to the construction of maps of interactors polypeptides
EP1002865A1 (en) *	1998-10-30	2000-05-24	Sanofi-Synthelabo	Adipose specific protein
AU4652600A (en) *	1999-04-23	2000-11-10	Curagen Corporation	Method of identifying ligands for the peroxisome proliferator activated receptorgamma using differential gene expression
WO2002008425A2 (en) *	2000-07-21	2002-01-31	Genaissance Pharmaceuticals, Inc.	Haplotypes of the adrb3 gene

2002
- 2002-03-14 WO PCT/EP2002/003768 patent/WO2002086122A2/en not_active Ceased
- 2002-03-14 AU AU2002304814A patent/AU2002304814A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2002086122A9 (en)	2003-12-18
WO2002086122A3 (en)	2003-10-30
WO2002086122A2 (en)	2002-10-31

Publication	Publication Date	Title
AU2002304814A1 (en)	2002-11-05	Protein-protein interactions in adipocytes
AUPS198302A0 (en)	2002-06-06	Improvements in bowsprits
AU2002240892A1 (en)	2002-07-16	Protein-protein interactions in adipocyte cells
AU2002301354A1 (en)	2003-06-12	Improvements in Transmissometers
AU2002301358A1 (en)	2003-06-12	Improvements in Transmissometers
AU2002343025A1 (en)	2003-06-10	Improvements in footwear
AU2001272655A1 (en)	2002-02-05	Improvements in valves
AU2002302851A1 (en)	2003-01-08	Atopy
AU2002248299A1 (en)	2002-08-28	Protein-protein interactions
AU2002230895A1 (en)	2002-07-01	Protein-protein interactions
AU2002245214A1 (en)	2002-07-16	Protein-protein interactions
AU2001268621A1 (en)	2002-01-02	Protein-protein interactions
AU2001263325A1 (en)	2001-12-03	Protein-protein interactions
AU2002249808A1 (en)	2002-07-24	Protein-protein interactions
AU2002236645A1 (en)	2002-07-01	Protein-protein interactions
AU2002230728A1 (en)	2002-06-24	Protein-protein interactions
AU2002331435A1 (en)	2003-04-01	Construction methods in space
AUPR473801A0 (en)	2001-05-31	Improvements in components
AU2002343038A1 (en)	2003-06-10	Improvements in keyboards
AUPR808601A0 (en)	2001-10-25	Improvements in levels
AU2002238704A1 (en)	2002-09-24	Improvements in insulating materials
AUPR889301A0 (en)	2001-12-06	Improvements in cylinders
AU2002253805A1 (en)	2002-08-28	Protein-protein interactions
AU2002245135A1 (en)	2002-07-30	Protein-protein interactions
AU2002231064A1 (en)	2002-07-01	Protein-protein interactions

Legal Events

Date	Code	Title	Description
2004-02-12	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase